← Evidence map

ArticleCancers2024

Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.

Samuel J Holzmayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 38610966